Compare Starter Dose Side Effects: Wegovy vs Mounjaro
Wegovy Side Effects vs Mounjaro: Starter Dose Differences
When comparing Wegovy side effects vs Mounjaro during the starter phase, the key difference lies in their dosing approach and mechanism of action. Wegovy begins with a conservative 0.25mg dose for weeks 1-4, designed to minimise gastrointestinal side effects whilst your body adjusts to semaglutide. This gentle introduction typically results in mild nausea affecting around 20% of patients, with most symptoms subsiding within the first two weeks.
Mounjaro starts at 2.5mg tirzepatide, which may produce more pronounced initial side effects due to its dual GIP and GLP-1 receptor activation. The dual mechanism can intensify gastrointestinal effects, with nausea reported in approximately 12-22% of patients during the first month. However, Mounjaro's side effects often resolve more quickly due to rapid tolerance development to the dual hormone action.
Pricing Comparison: Wegovy vs Mounjaro Starter Options
Wegovy's 0.25mg starter dose costs £79.99 for your first month's supply, making it an accessible entry point for weight management treatment. New customers can apply discount code FIRST40 at checkout to reach this price, whilst returning patients use DOSE25. Our Intro Duo bundle combines your first two doses (0.25mg and 0.5mg) for £169.99, providing seamless progression into weeks 5-8 without additional orders.
Mounjaro's pricing structure differs, with the 2.5mg starter dose typically costing more due to the complex dual-agonist formulation. Both Wegovy and Mounjaro are available from EverydayMeds with identical prescriber review processes and next-day cold-chain delivery. Your clinical assessment will help determine which starter dose profile suits your tolerance preferences and medical history.
Clinical Evidence: Wegovy Side Effects vs Mounjaro Tolerability
Clinical trials demonstrate distinct side effect patterns when comparing Wegovy vs Mounjaro starter doses. The STEP 1 trial showed that Wegovy's gradual dose escalation beginning at 0.25mg resulted in lower discontinuation rates due to gastrointestinal adverse events compared to faster titration schedules. Wilding et al., NEJM, 2021, reported that most patients tolerated the 0.25mg starter dose well, with side effects typically mild to moderate.
Mounjaro's SURMOUNT trials revealed that whilst initial side effects may be more frequent due to the higher starting dose, the dual incretin action often leads to faster appetite suppression effects. The 2.5mg starter dose activates both GIP and GLP-1 pathways simultaneously, which may cause more immediate satiety signals but potentially stronger initial nausea in sensitive individuals.
How Wegovy Works: GLP-1 Mechanism and Side Effect Profile
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural incretin hormone to regulate appetite and glucose metabolism. The 0.25mg starter dose gently activates GLP-1 receptors in your brain's appetite centres, promoting feelings of fullness after smaller meals whilst reducing food cravings. This gradual activation explains why Wegovy side effects vs Mounjaro tend to be milder initially, as your system adapts slowly to the single-hormone pathway. The prescription-only medicine works alongside a reduced-calorie diet and increased physical activity to support sustainable weight management. Side effects like mild nausea, reduced appetite, and occasional fatigue typically emerge within 48-72 hours of your first injection but often diminish as your body adjusts to the semaglutide mechanism.
EverydayMeds Ordering Process: Getting Started Safely
Beginning your Wegovy or Mounjaro journey with EverydayMeds starts with a comprehensive 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Our qualified prescribers review your assessment within 3 working days (or 24 hours with express service), ensuring the chosen treatment and starter dose are appropriate for your individual circumstances. Once approved, your prescription-only medicine is dispatched via next-day delivery using temperature-controlled cold-chain logistics to maintain medication integrity. Our GPhC-registered pharmacy (#9012878) provides detailed injection guidance and side effect monitoring support throughout your treatment journey. The seamless process ensures you receive expert medical oversight whilst comparing Wegovy side effects vs Mounjaro options in a safe, regulated environment.
Storage and Practical Considerations: Wegovy vs Mounjaro
Wegovy offers superior storage flexibility compared to Mounjaro, remaining stable for up to 6 weeks at room temperature below 30°C once removed from refrigeration, versus Mounjaro's 21-day room temperature limit. Both medications require refrigeration at 2-8°C before first use and come in pre-filled FlexTouch pens for convenient once-weekly self-injection. Wegovy's mandatory dose escalation schedule progresses through 0.25mg, 0.5mg, 1mg, 1.7mg, before reaching the 2.4mg maintenance dose at week 17, whilst Mounjaro follows its own titration protocol starting at 2.5mg. The storage advantage makes Wegovy more suitable for frequent travellers or those with limited refrigeration access, potentially influencing your choice when weighing Wegovy side effects vs Mounjaro practical considerations.
Managing Starter Dose Side Effects: Wegovy vs Mounjaro Strategies
Successfully managing Wegovy side effects vs Mounjaro during your starter phase requires different approaches due to their distinct mechanisms. Wegovy's 0.25mg dose allows gradual adjustment with simple strategies like eating smaller, frequent meals and avoiding high-fat foods that may exacerbate nausea. The slower onset of appetite changes gives you time to establish new eating patterns without overwhelming gastrointestinal distress.
Mounjaro's 2.5mg starter dose may require more proactive side effect management due to the immediate dual-hormone activation. Staying well-hydrated, eating slowly, and timing injections before lighter meal days can help minimise initial discomfort. Both treatments benefit from consistent injection timing and gradual dietary adjustments, but Mounjaro users often need closer monitoring during the first two weeks of treatment.
Expert Prescriber Guidance: Choosing Your Optimal Starter Dose
Selecting between Wegovy side effects vs Mounjaro requires personalised medical assessment considering your previous medication sensitivities, gastrointestinal health, and weight management history. Our experienced prescribers at EverydayMeds evaluate factors like your tolerance to appetite suppressants, history of nausea or digestive issues, and lifestyle requirements when recommending your optimal starter approach. Whether you choose Wegovy's gentle 0.25mg introduction or Mounjaro's more immediate 2.5mg activation, ongoing clinical support ensures safe progression through your weight management journey. Apply discount codes FIRST40 (new customers) or DOSE25 (returning patients) at checkout to access these prescription treatments from our GPhC-registered pharmacy. Visit https://everydaymeds.co.uk/products/wegovy-0-25mg to begin your clinical assessment today, with both Wegovy and Mounjaro available through our expert prescriber network.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
